- Home
- BSTZ vs INVA Comparison
BSTZ vs INVA Comparison
Compare BSTZ & INVA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- BSTZ
- INVA
- Stock Information
- Founded
- BSTZ 2019
- INVA 1996
- Country
- BSTZ United States
- INVA United States
- Employees
- BSTZ N/A
- INVA N/A
- Industry
- BSTZ Trusts Except Educational Religious and Charitable
- INVA Biotechnology: Pharmaceutical Preparations
- Sector
- BSTZ Finance
- INVA Health Care
- Exchange
- BSTZ Nasdaq
- INVA Nasdaq
- Market Cap
- BSTZ 1.5B
- INVA 1.3B
- IPO Year
- BSTZ N/A
- INVA 2004
- Fundamental
- Price
- BSTZ $22.05
- INVA $19.34
- Analyst Decision
- BSTZ
- INVA Strong Buy
- Analyst Count
- BSTZ 0
- INVA 4
- Target Price
- BSTZ N/A
- INVA $40.25
- AVG Volume (30 Days)
- BSTZ 303.2K
- INVA 641.1K
- Earning Date
- BSTZ 01-01-0001
- INVA 11-05-2025
- Dividend Yield
- BSTZ 8.31%
- INVA N/A
- EPS Growth
- BSTZ N/A
- INVA N/A
- EPS
- BSTZ 0.71
- INVA 0.53
- Revenue
- BSTZ N/A
- INVA $370,229,000.00
- Revenue This Year
- BSTZ N/A
- INVA $8.17
- Revenue Next Year
- BSTZ N/A
- INVA $12.06
- P/E Ratio
- BSTZ $26.69
- INVA $36.23
- Revenue Growth
- BSTZ N/A
- INVA 12.02
- 52 Week Low
- BSTZ $14.11
- INVA $16.67
- 52 Week High
- BSTZ $19.43
- INVA $22.00
- Technical
- Relative Strength Index (RSI)
- BSTZ 52.06
- INVA 50.98
- Support Level
- BSTZ N/A
- INVA N/A
- Resistance Level
- BSTZ $22.59
- INVA $21.11
- Average True Range (ATR)
- BSTZ 0.26
- INVA 0.45
- MACD
- BSTZ -0.81
- INVA -0.87
- Stochastic Oscillator
- BSTZ 97.61
- INVA 91.57
About BSTZ BlackRock Science and Technology Term Trust of Beneficial Interest
BlackRock Science and Technology Trust II is a non-diversified, closed-end management investment company. The trust's investment objectives are to provide total return and income through a combination of current income, current gains, and long-term capital appreciation. Its portfolio consists of Equity Securities, Options, Preferred Securities, Convertible Securities, Depositary Receipts, Non-U.S. Securities, Emerging Markets Investments, Restricted and Illiquid Investments, Private Company Investments, Corporate Bonds, and other investments. The trust seeks to Invest at least 80% of its total assets in equity securities issued by U.S. and non-U.S. science and technology companies in any market capitalization range from the development, advancement, and use of science and/or technology.
About INVA Innoviva Inc.
Innoviva Inc is a company with a portfolio of royalties healthcare assets. It has three primary sets of assets: a royalty portfolio, operating assets in critical care and infectious disease, and other strategic healthcare assets. Its product offering includes Relvar/Breo/Ellipta, Anoro, Ellipta, Trelegy, Ellipta and others.